Abiomed (FRA:AIO) COGS-to-Revenue : 0.18 (As of Sep. 2022)

View and export this data going back to 1987. Start your Free Trial

What is Abiomed COGS-to-Revenue?

Abiomed's Cost of Goods Sold for the three months ended in Sep. 2022 was €49 Mil. Its Revenue for the three months ended in Sep. 2022 was €269 Mil.

Abiomed's COGS to Revenue for the three months ended in Sep. 2022 was 0.18.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Abiomed's Gross Margin % for the three months ended in Sep. 2022 was 81.62%.

Abiomed COGS-to-Revenue Historical Data

The historical data trend for Abiomed's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abiomed COGS-to-Revenue Chart

Abiomed Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

COGS-to-Revenue

Get a 7-Day Free Trial

0.17

0.18

0.19

0.18

Abiomed Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
COGS-to-Revenue	Get a 7-Day Free Trial															0.18	0.18	0.19	0.19	0.18

Abiomed COGS-to-Revenue Calculation

Abiomed's COGS to Revenue for the fiscal year that ended in Mar. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	170.848	/	936.832
	=	0.18

Abiomed's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	49.369	/	268.58
	=	0.18

Abiomed (FRA:AIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Abiomed's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	49.369 / 268.58
	=	81.62 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Abiomed COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abiomed's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Abiomed (FRA:AIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abiomed Inc (FRA:AIO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Cherry Hill Drive, Danvers, MA, USA, 01923

Website

https://www.abiomed.com

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.